NASDAQ: CDTX
Cidara Therapeutics Inc Stock Ownership - Who owns Cidara Therapeutics?

Insider buying vs selling

Have Cidara Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Leslie TariCHIEF SCIENTIFIC OFFICER2025-03-111,773$21.96
$38.94kSell
Shane WardCOO CLO2025-03-111,664$21.96
$36.54kSell
Ra Capital Management LPDirector2024-11-26389,716$14.91
$5.81MBuy
Taylor SandisonChief Medical Officer2024-09-11924$11.64
$10.75kSell
Leslie TariCHIEF SCIENTIFIC OFFICER2024-09-11909$11.64
$10.58kSell
Jeffrey SteinPresident CEO2024-06-078,000$13.21
$105.68kBuy

1 of 1

CDTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CDTX insiders and whales buy or sell their stock.

CDTX Shareholders

What type of owners hold Cidara Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ag Mundipharma43.65%4,781,408$100.55MInsider
Target N. V. Biotech20.95%2,295,272$48.27MInsider
Nina S. Kjellson12.39%1,356,813$28.53MInsider
Ra Capital Management LP9.98%1,092,796$22.98MInsider
Bvf Inc9.98%1,092,796$22.98MInstitution
Ra Capital Management LP9.98%1,092,796$22.98MInstitution
Steve Elms9.63%1,054,610$22.18MInsider
Tcg Crossover Management LLC9.18%1,005,901$21.15MInstitution
Vr Adviser LLC6.99%765,723$16.10MInstitution
Aisling Capital II LP6.42%703,092$14.79MInsider

1 of 3

CDTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CDTX34.46%65.54%Net BuyingNet Selling
PLX3.18%96.82%
THRD66.17%33.83%Net Selling
RZLT29.06%70.94%Net BuyingNet Buying
CADL37.95%33.37%Net SellingNet Selling

Cidara Therapeutics Stock Ownership FAQ

Who owns Cidara Therapeutics?

Cidara Therapeutics (NASDAQ: CDTX) is owned by 62.75% institutional shareholders, 119.35% Cidara Therapeutics insiders, and 0.00% retail investors. Ag Mundipharma is the largest individual Cidara Therapeutics shareholder, owning 4.78M shares representing 43.65% of the company. Ag Mundipharma's Cidara Therapeutics shares are currently valued at $100.98M.

If you're new to stock investing, here's how to buy Cidara Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.